Phase II Clinical Trial Using Humira in Netherton Syndrome
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Congenital ichthyosiform erythroderma
- Focus Therapeutic Use
- Acronyms AntiTNF-SN
- 11 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 27 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 12 Nov 2015 Planned end date changed from 1 Dec 2016 to 1 Jun 2017, as reported by ClinicalTrials.gov.